-
Je něco špatně v tomto záznamu ?
Salivary gland cancer: ESMO-European Reference Network on Rare Adult Solid Cancers (EURACAN) Clinical Practice Guideline for diagnosis, treatment and follow-up
C. van Herpen, V. Vander Poorten, A. Skalova, C. Terhaard, R. Maroldi, A. van Engen, B. Baujat, LD. Locati, AD. Jensen, L. Smeele, J. Hardillo, VC. Martineau, A. Trama, E. Kinloch, C. Even, JP. Machiels, ESMO Guidelines Committee. Electronic...
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu směrnice pro lékařskou praxi
NLK
Directory of Open Access Journals
od 2016
PubMed Central
od 2016
Europe PubMed Central
od 2016
Open Access Digital Library
od 2016-01-01
Elsevier Open Access Journals
od 2016
ROAD: Directory of Open Access Scholarly Resources
od 2016
- MeSH
- dospělí MeSH
- lékařská onkologie MeSH
- lidé MeSH
- nádory slinných žláz * diagnóza terapie MeSH
- následné studie MeSH
- Check Tag
- dospělí MeSH
- lidé MeSH
- Publikační typ
- směrnice pro lékařskou praxi MeSH
- Geografické názvy
- Evropa MeSH
• This ESMO–EURACAN Clinical Practice Guideline provides key recommendations for managing salivary gland cancer. • The guideline covers clinical and pathological diagnosis, staging and risk assessment, treatment and follow-up. • Treatment algorithms for parotid, submandibular, sublingual and minor salivary gland cancer are provided. • The author group encompasses a multidisciplinary group of experts from different institutions and countries in Europe. • Recommendations are based on available scientific data and the authors’ collective expert opinion.
Department of Medical Oncology Radboud University Medical Center Nijmegen The Netherlands
Department of Oncology Section Head and Neck Oncology KU Leuven Leuven
Department of Otorhinolaryngology Head and Neck Surgery University Hospitals Leuven Leuven Belgium
Department of Pathology Charles University Faculty of Medicine in Plzen Plzen Czech Republic
Department of Pathology CHU Montpellier Montpellier France
Department of Pathology Radboud University Medical Center Nijmegen The Netherlands
Department of Radiation Oncology University Hospitals Gießen and Marburg Ltd Gießen Germany
Department of Radiology ASST Spedali Civili Brescia University of Brescia Brescia Italy
Department of Radiotherapy University Medical Center Utrecht The Netherlands
Faculty of Medicine Philipps University Marburg Marburg
French Network for Rare Head and Neck Cancers Paris France
Head and Neck Department Gustave Roussy Paris
Head and Neck Medical Oncology Unit Fondazione IRCCS Istituto Nazionale dei Tumori Milan Italy
Institut de Recherche Clinique et Expérimentale Université Catholique de Louvain Brussels Belgium
Multidisciplinary Salivary Gland Society Geneva Switzerland
Multidisciplinary Salivary Gland Society Geneva Switzerland https twitter com myESMO
Salivary Gland Cancer UK London UK
Service d'Oncologie Médicale Institut Roi Albert 2 Cliniques Universitaires Saint Luc Brussels
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22032271
- 003
- CZ-PrNML
- 005
- 20230131151756.0
- 007
- ta
- 008
- 230120s2022 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.esmoop.2022.100602 $2 doi
- 035 __
- $a (PubMed)36567082
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a van Herpen, C $u Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands; Multidisciplinary Salivary Gland Society, Geneva, Switzerland. Electronic address: https://twitter.com/myESMO
- 245 10
- $a Salivary gland cancer: ESMO-European Reference Network on Rare Adult Solid Cancers (EURACAN) Clinical Practice Guideline for diagnosis, treatment and follow-up / $c C. van Herpen, V. Vander Poorten, A. Skalova, C. Terhaard, R. Maroldi, A. van Engen, B. Baujat, LD. Locati, AD. Jensen, L. Smeele, J. Hardillo, VC. Martineau, A. Trama, E. Kinloch, C. Even, JP. Machiels, ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org
- 520 9_
- $a • This ESMO–EURACAN Clinical Practice Guideline provides key recommendations for managing salivary gland cancer. • The guideline covers clinical and pathological diagnosis, staging and risk assessment, treatment and follow-up. • Treatment algorithms for parotid, submandibular, sublingual and minor salivary gland cancer are provided. • The author group encompasses a multidisciplinary group of experts from different institutions and countries in Europe. • Recommendations are based on available scientific data and the authors’ collective expert opinion.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a následné studie $7 D005500
- 650 _2
- $a lékařská onkologie $7 D008495
- 650 12
- $a nádory slinných žláz $x diagnóza $x terapie $7 D012468
- 651 _2
- $a Evropa $7 D005060
- 655 _2
- $a směrnice pro lékařskou praxi $7 D017065
- 700 1_
- $a Vander Poorten, V $u Multidisciplinary Salivary Gland Society, Geneva, Switzerland; Department of Oncology, Section Head and Neck Oncology, KU Leuven, Leuven; Department of Otorhinolaryngology, Head and Neck Surgery, University Hospitals Leuven, Leuven, Belgium
- 700 1_
- $a Skalova, A $u Multidisciplinary Salivary Gland Society, Geneva, Switzerland; Department of Pathology, Charles University, Faculty of Medicine in Plzen, Plzen, Czech Republic
- 700 1_
- $a Terhaard, C $u Multidisciplinary Salivary Gland Society, Geneva, Switzerland; Department of Radiotherapy, University Medical Center, Utrecht, The Netherlands
- 700 1_
- $a Maroldi, R $u Department of Radiology, ASST Spedali Civili Brescia-University of Brescia, Brescia, Italy
- 700 1_
- $a van Engen, A $u Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands
- 700 1_
- $a Baujat, B $u Department of Otorhinolaryngology, Head and Neck Surgery, Sorbonne Université Hôpital Tenon, Assistance Publique Hôpitaux de Paris, Paris, France
- 700 1_
- $a Locati, L D $u Head and Neck Medical Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
- 700 1_
- $a Jensen, A D $u Faculty of Medicine, Philipps-University Marburg, Marburg; Department of Radiation Oncology, University Hospitals Gießen and Marburg (UKGM) Ltd, Gießen, Germany
- 700 1_
- $a Smeele, L $u Department of Head and Neck Oncology and Surgery, Antoni van Leeuwenhoek Ziekenhuis & Amsterdam UMC, Amsterdam
- 700 1_
- $a Hardillo, J $u Department of Otorhinolaryngology, Head and Neck Surgery, Erasmus University Medical Center, Rotterdam, The Netherlands
- 700 1_
- $a Martineau, V Costes $u Department of Pathology, CHU Montpellier, Montpellier, France
- 700 1_
- $a Trama, A $u Evaluative Epidemiology, Department of Research, Fondazione IRCSS Istituto Nazionale dei Tumori, Milan, Italy
- 700 1_
- $a Kinloch, E $u Salivary Gland Cancer UK, London, UK
- 700 1_
- $a Even, C $u Head and Neck Department, Gustave Roussy, Paris; French Network for Rare Head and Neck Cancers, Paris, France
- 700 1_
- $a Machiels, J-P $u Service d'Oncologie Médicale, Institut Roi Albert II, Cliniques Universitaires Saint-Luc, Brussels; Institut de Recherche Clinique et Expérimentale, Université Catholique de Louvain (UCLouvain), Brussels, Belgium
- 710 2_
- $a ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org
- 773 0_
- $w MED00196632 $t ESMO open $x 2059-7029 $g Roč. 7, č. 6 (2022), s. 100602
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/36567082 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20230120 $b ABA008
- 991 __
- $a 20230131151752 $b ABA008
- 999 __
- $a ok $b bmc $g 1891179 $s 1183606
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2022 $b 7 $c 6 $d 100602 $e 20221102 $i 2059-7029 $m ESMO open $n ESMO Open $x MED00196632
- LZP __
- $a Pubmed-20230120
